Eruptive keratoacanthomas arising in the setting of lichenoid toxicity after programmed cell death 1 inhibition with nivolumab
Author:
Affiliation:
1. Department of Dermatology; University of California-Davis; Sacramento CA USA
2. Department of Medicine; University of California-Davis; Sacramento CA USA
3. Department of Pathology; University of California-Davis; Sacramento CA USA
Publisher
Wiley
Subject
Infectious Diseases,Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14503/fullpdf
Reference6 articles.
1. Two cases of anti-programmed cell death 1-associated bullous pemphigoid-like disease and eruptive keratoacanthomas featuring combined histopathology;Bandino;J Eur Acad Dermatol Venereol,2017
2. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy;Curry;J Cutan Pathol,2017
3. Lichenoid dermatologic toxicity from immune checkpoint blockade therapy: a detailed examination of the clinicopathologic features;Tetzlaff;Am J Dermatopathol,2017
4. Eruptive keratoacanthomas associated with pembrolizumab Therapy;Freites-Martinez;JAMA Dermatol,2017
5. Keratoacanthoma arising in hypertrophic lichen planus;Badell;Br J Dermatol,2000
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Eruptive Keratoacanthomas After Nivolumab Treatment of Stage III Melanoma;Cutis;2023-05
2. To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma;Archives of Dermatological Research;2022-11-17
3. Multiple eruptive squamoproliferative lesions during anti‐PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment;Dermatologic Therapy;2022-04-05
4. Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy;Journal of the European Academy of Dermatology and Venereology;2022-01-28
5. Spironolactone-Induced Lichenoid Drug Reaction and Subsequent Diffuse Eruptive Squamous Cell Carcinomas Successfully Treated With Systemic Methotrexate;Cureus;2021-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3